Abstract
This review addresses classical and novel aspects of the brain angiotensin system. The brain contains both the AT1 and AT2 angiotensin II (Ang II) receptor subtypes which are well-characterized guanine nucleotide binding protein (G protein)-coupled receptors (GPCRs). Like other GPCRs, novel signal transduction pathways and protein interactions are being described for Ang II receptors. For brain AT1 receptors, there is a controversy regarding the identity of the active angiotensin peptide in the brain which is addressed in this review. This review also summarizes a recent discovery of a novel, membrane-bound, non-AT1, non-AT2 binding site for angiotensin peptides that appears to be brain-specific. This binding site is unmasked by a limited concentration range of the organometallic sulfhydryl-reactive agent p-chloromercuribenzoic acid (PCMB) suggesting that functional expression of this binding site may depend on the redox state of the milieu of the brain. While this binding site has similarities to a previously described soluble angiotensin-binding protein found in liver that is unmasked by PCMB, it has many different characteristics. The possible functional significance of this novel non-AT1, non-AT2 binding site for angiotensin peptides as a mediator of non-traditional actions of Ang II in the brain, e.g., stimulation of dopamine release from the striatum, as a peptidase, or as a clearance receptor, and the importance of the state of the internal environment of the brain to its function is reviewed.
Similar content being viewed by others
Reference
AbdAlla S, Lother H, Quitterer U (2000) AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407:94–98
AbdAlla S, Lother H, Langer A, el Faramawy Y, Quitterer U (2004) Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 119:343–354
Armstrong DL, Garcia EA, Ma T, Quinones B, Wayner MJ (1996) Angiotensin II blockade of long-term potentiation at the perforant path-granule cell synapse in vitro. Peptides 17:689–693
Barnes JM, Barnes NM, Costall B, Horovitz ZP, Naylor RJ (1989) Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro. Brain Res 491:136–143
Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, Runswick MJ, Murphy MP (2004) Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant defense. J Biol Chem 279:47939–47951
Bennett Jr JP, Snyder SH (1976) Angiotensin II binding to mammalian brain membranes. J Biol Chem 251:7423–7430
Bickerton RK, Buckley JP (1961) Evidence for a central mechanism in angiotensin induced hypertension. Proc Soc Exp Biol Med 106:834–836
Biswas S, Chida AS, Rahman I (2006) Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol 71:551–564
Booth DA (1968) Mechanism of action of norepinephrine in eliciting an eating response on injection into the rat hypothalamus. J Pharmacol Exp Ther 160:336–348
Campanile CP, Crane JK, Peach MJ, Garrison JC (1982) The hepatic angiotensin II receptor 1. Characterization of the membrane-binding site and correlation with physiological response in hepatocytes. J Biol Chem 257:4951–4958
Catt KJ, Mendelsohn FA, Millan MA, Aguilera G (1984) The role of angiotensin II receptors in vascular regulation. J Cardiovasc Pharmacol 6(Suppl 4):S575–S586
Chiu AT, McCall DE, Nguyen TT, Carini DJ, Duncia JV, Herblin WF, Uyeda RT, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWM (1989) Discrimination of angiotensin II receptor subtypes by dithiothreitol. Eur J Pharmacol 170:117–118
Dahms P, Mentlein R (1992) Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16. Eur J Biochem 208:145–154
Daviet L, Lehtonen JY, Tamura K, Griese DP, Horiuchi M, Dzau VJ (1999) Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem 274:17058–17062
Falcon BL, Stewart JM, Bourassa E, Katovich MJ, Walter G, Speth RC, Sumners C, Raizada MK (2004) Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension. Physiol Genomics 19:255–261
Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53:1–24
Foltermann KF, Shanley MS, Wild JR (1984) Assembly of the aspartate transcarbamoylase holoenzyme from transcriptionally independent catalytic and regulatory cistrons. J Bacteriol 157:891–898
Fournie-Zaluski MC, Fassot C, Valentin B, Djordjijevic D, Reaux-Le Goazigo A, Corvol P, Roques BP, Llorens-Cortes C (2004) Brain renin–angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Proc Natl Acad Sci U S A 101:7775–7780
Fujii T, Onohara N, Maruyama Y, Tanabe S, Kobayashi H, Fukutomi M, Nagamatsu Y, Nishihara N, Inoue R, Sumimoto H, Shibasaki F, Nagao T, Nishida M, Kurose H (2005) Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts. J Biol Chem 280:23041–23047
Fujioka H, Okabe T, Yamaguchi H (1995) Purification and characterization of angiotensin II degradation factor from porcine endothelial cells. Tohoku J Exp Med 177:183–192
Ganten D, Minnich JL, Granger P, Hayduk K, Brecht HM, Barbeau A, Boucher R, Genest J (1971) Angiotensin-forming enzyme in brain tissue. Science 173:64–65
Gehlert DR, Gackenheimer SL, Schober DA (1991) Angiotensin II receptor subtypes in rat brain: dithiothreitol inhibits ligand binding to AII-1 and enhances binding to AII-2. Brain Res 546:161–165
Ghezzi P (2005) Regulation of protein function by glutathionylation. Free Radic Res 39:573–580
Glass MJ, Huang J, Speth RC, Iadecola C, Pickel VM (2005) Angiotensin II AT-1A receptor immunolabeling in rat medial nucleus tractus solitarius neurons: subcellular targeting and relationships with catecholamines. Neuroscience 130:713–723
Glossmann H, Baukal AJ, Catt KJ (1974) Properties of angiotensin II receptors in the bovine and rat adrenal cortex. J Biol Chem 249:825–834
Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE (1991) Expression of the type 2 angiotensin receptor in the developing rat fetus. FASEB J 5:A869
Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141–1148
Guo S, Lopez-Ilasaca M, Dzau VJ (2005) Identification of calcium-modulating cyclophilin ligand (CAML) as transducer of angiotensin II-mediated nuclear factor of activated T cells (NFAT) activation. J Biol Chem 280:12536–12541
Hagiwara H, Sugiura N, Wakita K, Hirose S (1989) Purification and characterization of angiotensin-binding protein from porcine liver cytosolic fraction. Eur J Biochem 185:405–410
Harding JW, Felix D (1987) Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III. Brain Res 410:130–134
Horiuchi M, Lehtonen JY, Daviet L (1999) Signaling Mechanism of the AT2 Angiotensin II Receptor: crosstalk between AT1 and AT2 receptors in cell growth. Trends Endocrinol Metab 10:391–396
Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T (1993) Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268:24543–24546
Kang J, Richards EM, Posner P, Sumners C (1995) Modulation of the delayed rectifier K+ current in neurons by an angiotensin II type 2 receptor fragment. Am J Physiol 268:C278–C282
Karamyan VT, Gadepalli R, Rimoldi J, Speth RC (2007) Preservation of 125-I-Angiotensin II in brain AT-1 receptor binding assays. Exerimental Biology Meeting Program number 571.3
Karamyan VT, Speth RC (2007a) Enzymatic pathways of the brain renin–angiotensin system: unsolved problems and continuing challenges. Regul Pept 143:15–27
Karamyan VT, Speth RC (2007b) Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain. Brain Res 1143:83–91
Karlin A, Bartels E (1966) Effects of blocking sulfhydryl groups and of reducing disulfide bonds on the acetylcholine-activated permeability system of the electroplax. Biochim Biophys Acta 126:525–535
Karniski LP (1989) Activation of Cl-/OH- exchange by parachloromercuribenzoic acid in rabbit renal brush-border membranes. J Membr Biol 112:59–66
Kato A, Sugiura N, Hagiwara H, Hirose S (1994) Cloning, amino acid sequence and tissue distribution of porcine thimet oligopeptidase. A comparison with soluble angiotensin-binding protein. Eur J Biochem 221:159–165
Kiron MA, Soffer RL (1989) Purification and properties of a soluble angiotensin II- binding protein from rabbit liver. J Biol Chem 264:4138–4142
Kohara K, Tabuchi Y, Senanayake P, Brosnihan KB, Ferrario CM (1991) Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides 12:1135–1141
Kokje RJ, Wilson WL, Brown TE, Karamyan VT, Wright JW, Speth RC (2007) Pressor actions of aminopeptidase-resistant analogs of angiotensin II in the rat brain: challenging the angiotensin III hypothesis. Hypertension 49:1328–1335
Kuriyama R, Miki-Noumura T (1975) Light-microscopic observations of individual microtubules reconstituted from brain tubulin. J Cell Sci 19:607–620
Lassegue B, Clempus RE (2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285:R277–R297
Lazard D, Villageois P, Briend-Sutren MM, Cavaille F, Bottari S, Strosberg AD, Nahmias C (1994) Characterization of a membrane glycoprotein having pharmacological and biochemical properties of an AT2 angiotensin II receptor from human myometrium. Eur J Biochem 220:919–926
Leichert LI, Jakob U (2006) Global methods to monitor the thiol-disulfide state of proteins in vivo. Antioxid Redox Signal 8:763–772
Lopachin RM, Barber DS (2006) Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants. Toxicol Sci 94:240–255
Maher P (2006) Redox control of neural function: background, mechanisms, and significance. Antioxid Redox Signal 8:1941–1970
Majumdar S, Bhattacharjee H, Bhattacharyya D, Bhaduri A (1998) UDP-galactose 4-epimerase from Kluyveromyces fragilis: reconstitution of holoenzyme structure after dissociation with parachloromercuribenzoate. Eur J Biochem 257:427–433
McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, Lefkowitz RJ (2000) Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290:1574–1577
McKie N, Dando PM, Rawlings ND, Barrett AJ (1993) Thimet oligopeptidase: similarity to ‘soluble angiotensin II- binding protein’ and some corrections to the published amino acid sequence of the rat testis enzyme. Biochem J 295:57–60
Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292:C82–C97
Mendelsohn FAO, Quirion R, Saavedra JM, Aguilera G, Catt KJ (1984) Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 81:1575–1579
Mendelsohn FA, Jenkins TA, Berkovic SF (1993) Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res 613:221–229
Mitchell DA, Vasudevan A, Linder ME, Deschenes RJ (2006) Protein palmitoylation by a family of DHHC protein S-acyltransferases. J Lipid Res 47:1118–1127
Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ (1993) Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 268:24539–24542
Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351:233–236
Olami Y, Rimon A, Gerchman Y, Rothman A, Padan E (1997) Histidine 225, a residue of the NhaA-Na+/H+ antiporter of Escherichia coli is exposed and faces the cell exterior. J Biol Chem 272:1761–1768
Olivares-Reyes JA, Smith RD, Hunyady L, Shah BH, Catt KJ (2001) Agonist-induced signaling, desensitization, and internalization of a phosphorylation-deficient AT1A angiotensin receptor. J Biol Chem 276:37761–37768
Oppermann M, Freedman NJ, Alexander RW, Lefkowitz RJ (1996) Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C. J Biol Chem 271:13266–13272
Qian H, Pipolo L, Thomas WG (2001) Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization. Mol Endocrinol 15:1706–1719
Reaux A, Fournie-Zaluski MC, David C, Zini S, Roques BP, Corvol P, Llorens-Cortes C (1999) Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci U S A 96:13415–13420
Reaux A, Fournie-Zaluski MC, Llorens-Cortes C (2001) Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endocrinol Metab 12:157–162
Rodbell M, Birnbaumer L, Pohl SL, Krans MJ (1971a) The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. J Biol Chem 246:1877–1882
Rodbell M, Krans MJ, Pohl SL, Birnbaumer L (1971b) The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. J Biol Chem 246:1872–1876
Rowe BP, Grove KL, Saylor DL, Speth RC (1990) Angiotensin II receptor subtypes in the rat brain. Eur J Pharmacol 186:339–342
Rowe BP, Saylor DL, Speth RC (1992) Analysis of angiotensin II receptor subtypes in individual rat brain nuclei. Neuroendocrinology 55:563–573
Saavedra JM (2005) Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 25:485–512
Sabri A, Govindarajan G, Griffin TM, Byron KL, Samarel AM, Lucchesi PA (1998) Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle. Circ Res 83:841–851
Satoh T, Lipton SA (2007) Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci 30:37–45
Severs WB, Daniels-Severs AE (1973) Effects of angiotensin on the central nervous system. Pharmacol Rev 25:415–449
Shirai H, Takahashi K, Katada T, Inagami T (1995) Mapping of G protein coupling sites of the angiotensin II type 1 receptor. Hypertension 25:726–730
Shivakumar BR, Wang Z, Hammond TG, Harris RC (2005) EP24.15 interacts with the angiotensin II type I receptor and bradykinin B2 receptor. Cell Biochem Funct 23:195–204
Shrimpton CN, Wolfson AJ, Smith AI, Lew RA (2003) Regulators of the neuropeptide-degrading enzyme, EC 3.4.24.15 (thimet oligopeptidase), in cerebrospinal fluid. J Neurosci Res 74:474–478
Sirett NE, McLean AS, Bray JJ, Hubbard JI (1977) Distribution of angiotensin II receptors in rat brain. Brain Res 122:299–312
Song LJ, Wilk S, Healy DP (1997) Aminopeptidase A antiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses. Brain Res 744:1–6
Speth RC, Rowe BP, Grove KL, Carter MR, Saylor DL (1991) Sulfhydryl reducing agents distinguish two subtypes of angiotensin II receptors in the rat brain. Brain Res 548:1–8
Sullivan MJ, Harding JW, Wright JW (1988) Differential effects of aminopeptidase inhibitors on angiotensin- induced pressor responses. Brain Res 456:249–253
Tamura K, Tanaka Y, Tsurumi Y, Azuma K, Shigenaga A, Wakui H, Masuda S, Matsuda M (2007) The role of angiotensin AT1 receptor-associated protein in renin–angiotensin system regulation and function. Curr Hypertens Rep 9:121–127
Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45:205–251
Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM (2002) beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277:9429–9436
Torrecilla I, Tobin AB (2006) Co-ordinated covalent modification of G-protein coupled receptors. Curr Pharm Des 12:1797–1808
Ushio-Fukai M, Griendling KK, Akers M, Lyons PR, Alexander RW (1998) Temporal dispersion of activation of phospholipase C-beta1 and -gamma isoforms by angiotensin II in vascular smooth muscle cells. Role of alphaq/11, alpha12, and beta gamma G protein subunits. J Biol Chem 273:19772–19777
Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK (1999) Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274:22699–22704
Veerasingham SJ, Raizada MK (2003) Brain renin–angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 139:191–202
Velu CS, Niture SK, Doneanu CE, Pattabiraman N, Srivenugopal KS (2007) Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 46:7765–7780
Venema RC, Ju H, Venema VJ, Schieffer B, Harp JB, Ling BN, Eaton DC, Marrero MB (1998) Angiotensin II-induced association of phospholipase Cgamma1 with the G- protein-coupled AT1 receptor. J Biol Chem 273:7703–7708
Wang C, Jayadev S, Escobedo JA (1995) Identification of a domain in the angiotensin II type 1 receptor determining Gq coupling by the use of receptor chimeras. J Biol Chem 270:16677–16682
Wang G, Anrather J, Huang J, Speth RC, Pickel VM, Iadecola C (2004) NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J Neurosci 24:5516–5524
Whitebread S, Mele M, Kamber B, de Gasparo M (1989) Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 163:284–291
Wright JW, Tamura-Myers E, Wilson WL, Roques BP, Llorens-Cortes C, Speth RC, Harding JW (2003) Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats. Am J Physiol Regul Integr Comp Physiol 284:R725–R733
Yamano Y, Ohyama K, Chaki S, Guo D-F, Inagami T (1992) Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. Biochem Biophys Res Commun 187:1426–1431
Yatani A, Kamp TJ (2000) Tails of the L-type Ca(2+) channel: to sense oxygen or not. Circ Res 87:535–536
Zeng C, Luo Y, Asico LD, Hopfer U, Eisner GM, Felder RA, Jose PA (2003) Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension 42:787–792
Zimmerman MC, Davisson RL (2004) Redox signaling in central neural regulation of cardiovascular function. Prog Biophys Mol Biol 84:125–149
Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL (2002) Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91:1038–1045
Zini S, Fournie-Zaluski MC, Chauvel E, Roques BP, Corvol P, Llorens-Cortes C (1996) Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: Predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 93:11968–11973
Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, Alexander RW (2005) Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 25:1824–1830
Acknowledgments
The work reported in this review is supported by the Peptide Radioiodination Service Center of the University of Mississippi. Vardan Karamyan is supported by the Peptide Radioiodination Service Center and National Institutes of Health Division of Research Resources Centers of Biomedical Research Excellence grant (RR-0212929). Losartan is a generous gift from Dr. Ron Smith of Dupont Merck, Whitehouse, NJ, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Speth, R.C., Karamyan, V.T. Brain angiotensin receptors and binding proteins. Naunyn-Schmied Arch Pharmacol 377, 283–293 (2008). https://doi.org/10.1007/s00210-007-0238-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-007-0238-7